Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central retinal vein occlusion case-control study.

Hideki Koizumi1, Daniela C Ferrara, Claudia Bruè

  • 1Vitreous-Retina-Macula Consultants of New York, New York, NY 10022, USA.

American Journal of Ophthalmology
|October 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for the SACLA trial: Efficacy and safety of subretinal monteplase for submacular hemorrhage in a phase II single-arm multicenter decentralized clinical trial.

PloS one·2026
Same author

Predictors of Good Visual Recovery in Patients With Spontaneously Resolved Acute CSCR - MICRoN Report Number Thirteen.

American journal of ophthalmology·2026
Same author

Mapping Resident Perspectives on Safety, Participation, and Security Devices: Insights into Community Security Governance in Urban China.

International journal of offender therapy and comparative criminology·2026
Same author

Evaluation of Melanin Changes in Acute Vogt-Koyanagi-Harada Disease Using Polarization-Sensitive Optical Coherence Tomography.

Investigative ophthalmology & visual science·2026
Same author

Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial.

Japanese journal of ophthalmology·2025
Same author

Impact of Reticular Pseudodrusen on Clinical and Ocular Characteristics and Progression Rate of Geographic Atrophy in Japanese Patients.

Ophthalmology science·2025
Same journal

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

American journal of ophthalmology·2026
Same journal

Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

American journal of ophthalmology·2026
Same journal

Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

American journal of ophthalmology·2026
Same journal

Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

American journal of ophthalmology·2026
Same journal

Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

American journal of ophthalmology·2026
See all related articles

This study identified glaucoma, aspirin use, and warfarin use as key independent risk factors for central retinal vein occlusion (CRVO). These findings suggest CRVO pathogenesis may be complex, potentially involving factors beyond simple thrombus formation.

Area of Science:

  • Ophthalmology
  • Vascular Medicine
  • Retinal Diseases

Background:

  • Central retinal vein occlusion (CRVO) is a significant cause of vision loss.
  • Understanding its risk factors is crucial for prevention and management.

Purpose of the Study:

  • To investigate and identify risk factors associated with central retinal vein occlusion (CRVO).

Main Methods:

  • Retrospective case-control study design.
  • Comparison of consecutive CRVO patients with a matched control group.
  • Evaluation of potential risk factors through univariate and multivariate analyses.

Main Results:

  • CRVO was associated with hypertension, diabetes mellitus, glaucoma, and atrial fibrillation.

Related Experiment Videos

  • Independent predictors identified were glaucoma (OR, 4.75), aspirin use (OR, 2.66), and warfarin use (OR, 3.34).
  • Postmenopausal estrogen use was less common in CRVO patients.

    • Conclusions:

    • Glaucoma, aspirin, and warfarin use are confirmed independent risk factors for CRVO.
    • Findings suggest CRVO pathogenesis may be more complex than primary thrombus formation.
    • Current antithrombotic therapies may not fully address vasculopathic and prothrombotic risks in all CRVO cases.